Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Ensysce Biosciences, Inc. Director's Dealing 2017

Dec 2, 2017

35337_dirs_2017-12-01_b29e2f9e-4ed3-4440-b77c-3874bbab9261.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Leisure Acquisition Corp. (LACQ)
CIK: 0001716947
Period of Report: 2017-12-01

Reporting Person: HG Vora Capital Management, LLC (10% Owner)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 3556250 Indirect

Footnotes

F1: Includes an aggregate of 375,000 shares beneficially owned by HG Vora Capital Management, LLC that are subject to forfeiture to the extent that the underwriters' overallotment option in the Company's initial public offering is not fully exercised. Includes an aggregate of 718,750 shares that are expected to be forfeited upon consummation of the Company's initial public offering pursuant to the securities subscription agreement by and between an affiliate of the reporting person and the Company.

F2: Securities owned directly by HG Vora Special Opportunities Master Fund, Ltd. ("HG Vora Special Opportunities"). HG Vora Capital Management, LLC ("HG Vora Capital") is a registered investment adviser under the Investment Advisers Act of 1940, as amended, and acts as an investment adviser to certain investment entities. HG Vora Capital, as investment manager of HG Vora Special Opportunities, may be deemed to beneficially own the securities owned directly by HG Vora Special Opportunities.